...
首页> 外文期刊>Mutation Research - Genetic Toxicology and Environmental Mutagenesis >An assay to detect DNA-damaging agents that induce nucleotide excision-repairable DNA lesions in living human cells
【24h】

An assay to detect DNA-damaging agents that induce nucleotide excision-repairable DNA lesions in living human cells

机译:检测DNA损伤剂的测定诱导诱导活性人体细胞中的核苷酸切除可修复的DNA病变的损伤剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Biochemical risk assessment studies of chemicals that induce DNA lesions are important, because lesions in genomic DNA frequently result in cancer, neurodegeneration, and aging in humans. Many classes of DNA lesions induced by chemical agents are eliminated via DNA repair mechanisms, such as nucleotide excision repair (NER) and base excision repair (BER), for the maintenance of genomic integrity. Individuals with NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions are not efficiently removed, are cancer-prone and suffer neurodegeneration. For research into cancer and neurological diseases, therefore, it might be important to identify DNA damage from agents that induce NER-repairable bulky DNA lesions. However, simple and quick assays to detect such damaging agents have not been developed using human cells. Here, we report a simple, non-isotopic assay for determining DNA damaging agents that induce NER-repairable DNA lesions by visualizing gene expression from treated fluorescent protein vectors in a mammalian cell system. This assay is based on a comparison of fluorescent protein expression in NER-proficient and NER-deficient cells. When we tested UV-irradiated fluorescent protein vectors, the fluorescent protein was observed in NER-proficient cells, but not in NER-deficient cells. Similar results were obtained for vectors treated with the anticancer drug, cisplatin. In contrast, when treated with the DNA alkylating agent methyl methanesulfonate, believed to cause BER-repairable damage, no difference in gene expression between NER-proficient and NER-deficient cells was observed. These results suggest that our assay can specifically detect DNA-damaging agents that induce NER-repairable DNA lesions, and could be used to analyze chemicals with the potential to cause cancer and neurological diseases. With further validation, the assay might be also applicable to XP diagnosis.
机译:诱导DNA病变的化学品的生化风险评估研究很重要,因为基因组DNA中的病变经常导致人类的癌症,神经变性和老化。通过DNA修复机制消除了由化学试剂诱导的许多类别的DNA病变,例如核苷酸切除修复(NER)和基础切除修复(BER),用于维持基因组完整性。具有Ner缺陷的Xeroderma Pigmentosum(XP)的个体,其中庞大的DNA病变未被有效地除去,是癌症 - 易受患者和遭受神经变性的。因此,对于癌症和神经疾病的研究,鉴定诱导诱导NER可修复的笨重DNA病变的药剂的DNA损伤可能是重要的。然而,尚未使用人体细胞进行简单且快速的测定来检测这种破坏剂。在这里,我们通过在哺乳动物细胞体系中的处理过的荧光蛋白载体中,确定一种简单的非同位素测定,用于确定诱导NER可修复的DNA病变的DNA损伤剂。该测定基于荧光蛋白表达在颞下细胞和缺乏细胞中的比较。当我们测试紫外线辐照的荧光蛋白载体时,在Ner易碎细胞中观察到荧光蛋白,但不在Ner缺陷细胞中观察到。获得了用抗癌药物,顺铂治疗的载体获得了类似的结果。相反,当用DNA烷基化剂处理甲醇磺酸甲酯处理时,被认为导致BER可修复的损伤,观察到Ner易受和缺乏细胞之间的基因表达没有差异。这些结果表明,我们的测定可以特异性地检测诱导NER可修复的DNA病变的DNA损伤剂,并且可用于分析化学品,潜力导致癌症和神经疾病。通过进一步验证,该测定可能也适用于XP诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号